Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria in Saliva and Bioaerosol Contamination
Status:
Completed
Trial end date:
2020-12-15
Target enrollment:
Participant gender:
Summary
To evaluate the anti-bacterial, pre-procedural, clinical efficacy of Peroxyl mouthwash (1.5%
hydrogen peroxide) in saliva and the reduction of bioaerosol contamination as compared to a
matching placebo mouthwash (0.0% hydrogen peroxide)